4see Ventures
Venture capitalChêne-Bougeries · Pre-Seed–Series B · 2 people tracked
Find your way into 4see Ventures
450 people in our graph share verified history with the 4see Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
4see ventures invests in emerging leaders across climatech, sustainability, and healthcare, aiming to help build game-changing companies globally. Its current investment focus is on Swiss early-stage startups in climatech and sustainability. The firm backs founders defined by a strong passion for their mission and a dedication to hard work, seeking entrepreneurs with the ambition to change the world, a clear vision to disrupt markets, and executable plans to bring that vision to life. The name reflects a philosophy of foresight — anticipating market developments, patterns, and trends before they fully unfold.
Source: firm website, verified Aug 7, 2026.
Team · 2 people
from the firm's website & public directories
What they invest in
from 7 of 9 portfolio companiesHealthtech ×3AI & Machine Learning ×2Biotech ×2Deep Tech ×2Medical Devices ×2Circular Economy ×1Construction Tech ×1Cybersecurity ×1
HQs:Switzerland×4
Investments · 9 tracked
founders shown can be your intro pathPartnerDaniel Bertholet· solo GP
Co-investorsBlockchain Valley Ventures, LlcKaristaKickstart Innovation
Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams.
HealthtechMedical DevicesRoboticsLausanne, CH
PartnerDaniel Bertholet· solo GP
Co-investors415 CapitalPrivilège VenturesZühlke Ventures
FenX develops proprietary materials technology for sustainable, circular construction, aiming to produce affordable living spaces that reduce waste and improve energy efficiency.
Circular EconomyConstruction TechNew MaterialsZurich, CH
Dr. Alessandro Dutto(Co-founder, Formulation)Enrico Scoccimarro(CSO & Co-founder)inDr. Etienne Jeoffroy(CEO & Co-founder)Jens Diebold(COO)
PartnerDaniel Bertholet· solo GP
Co-investorsSupernova InvestMove Energy
HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.
AI & Machine LearningBiotechDeep TechHealthtech
Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)inDaniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRichard Law(Chief Business Officer (CBO))inEric Adam(Chief Operating Officer (COO))inJordan Shin(Chief Medical Officer (CMO))inJérôme Andries(Chief Financial Officer (CFO))in
PartnerDaniel Bertholet· solo GP
Co-investorsBroadview VenturesSofinnova PartnersApollo Health Ventures+ND Capital
NetGuardians provides financial crime prevention intelligence software for detecting and preventing fraud, money laundering, and insider risk across banking institutions.
AI & Machine LearningCybersecurityFintechZurich, CH
PartnerDaniel Bertholet· solo GP
Co-investorsPolytech Ecosystem VenturesR136 VenturesACE & CompanyPictet Group
Priothera is a clinical-stage biotech developing mocravimod (an S1P receptor modulator) for hematologic malignancies such as acute myeloid leukemia.
BiotechHealthtech
Florent Gros(Chief Executive Officer and Founder)Stephan Oehen(Chief Operating Officer and Founder)inBrice Suire(Chief Financial Officer and Founder)Nigel Clark(Chief Business Officer)Jens Hasskarl(Chief Medical Officer)
PartnerDaniel Bertholet· solo GP
Co-investorsFountain Healthcare PartnersHealthCap
Transmutex develops accelerator-powered technology that converts nuclear waste into clean energy and produces medical radioisotopes.
Deep TechEnergyMedical Devices
Franklin Servan-Schreiber(Founder & CEO)in
PartnerDaniel Bertholet· solo GP
Co-investorsAlleyCorpAt One VenturesHCVCSteel AtlasUnion Square Ventures (USV)Verve Ventures+4 more
.jpeg){kind=logo}
Portfolio news
latest coverage across their companiesHaya Therapeutics · cen.acs.org · Jun 18, 2026
Goodwall · press.spglobal.com · May 14, 2026
Distalmotion · medtechdive.com · Apr 29, 2026
Transmutex · s-ge.com · Nov 4, 2025
FenX · hightechzentrum.ch · Oct 13, 2025
Frequently asked questions
- How many investments has 4see Ventures made?
- 4see Ventures has 9 tracked investments, including 1 dated in the last 24 months.
- What stage does 4see Ventures invest at?
- 4see Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is 4see Ventures's typical check size?
- 4see Ventures typically writes checks of $432K – $1.1M.
- What sectors does 4see Ventures focus on?
- 4see Ventures focuses on Biotech, Cleantech, Climate Tech, Consumer, Data & Infrastructure, Energy, Enterprise Software, Fintech, FoodTech, Healthtech, Impact & Social Good, Medical Devices, Robotics, SaaS.
- Where is 4see Ventures located?
- 4see Ventures is headquartered in Chêne-Bougeries, CH.
- Who does 4see Ventures co-invest with?
- 4see Ventures most often shares deals with AlleyCorp, At One Ventures, Blockchain Valley Ventures, Llc, among 20 tracked co-investors.
Co-investors · 3
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.
New Leaf Venture Partners is a venture capital firm investing in innovative healthcare companies.
Firms observed investing alongside 4see Ventures, from public investor directories. Shared companies are the overlap with 4see Ventures's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.